GGrantIndex
Sort

16,300 grants matching fatty liver disease

Obesity and Hepatic Steatosis

$260,291
Michael J Pagliassotti · Colorado State University · R01 · FY2006 · DK

METABOLIC CORE

$260,139
Jacob E Friedman · University Of Colorado Denver · P30 · FY2011 · DK

The Role of Leptin in Liver Fibrogenesis

$260,100
Emory University · R01 · FY2003 · DK

Human Translational Core

$260,066
Rohit Loomba · University Of California, San Diego · P30 · FY2020 · DK

Bridging Genomics and Medicine by Ontology Fingerprints

$260,000
Andrew B. Lawson · Medical University Of South Carolina · R56 · FY2012 · LM

Regulation of Natriuretic Peptide Signaling in Adipose Tissue and Energy Metabolism

$259,500
Sheila Collins · Vanderbilt University Medical Center · R56 · FY2020 · DK

Pathology and Biochemistry Core

$259,489
Kathryn J Moore · New York University School Of Medicine · P01 · FY2025 · HL

Project 1: Effects of Air Pollution on the Development of Obesity in Children

$259,329
Frank D. Gilliland · University Of Southern California · P01 · FY2016 · ES

3D Subharmonic Pressure Maps of Vulnerable Plaques

$259,244
Flemming Forsberg · Thomas Jefferson University · R21 · FY2014 · HL

Reversing the epigenetic code of aging through ketogenic diets

$259,200
Pier Giuseppe Pelicci · University Of California At Davis · P01 · FY2023 · AG

Reversing the epigenetic code of aging through ketogenic diets

$259,200
Pier Giuseppe Pelicci · University Of California At Davis · P01 · FY2020 · AG

Reversing the epigenetic code of aging through ketogenic diets

$259,200
Pier Giuseppe Pelicci · University Of California At Davis · P01 · FY2022 · AG

Hepatic Steatosis Modulation by Apo B Gene Transcription

$259,182
Janet D Sparks · University Of Rochester · R01 · FY2010 · DK

Molecular mechanisms of fatty liver disease: role of the protein DBC1

$259,164
Eduardo N Chini · Mayo Clinic Rochester · R01 · FY2011 · DK

Molecular mechanisms of fatty liver disease: role of the protein DBC1

$259,164
Eduardo N Chini · Mayo Clinic Rochester · R01 · FY2012 · DK

Molecular Determinants of Tumor Progression in A Steatolic Liver Microenvironment

$258,797
David L Gorden · Vanderbilt University · U01 · FY2013 · CA

Improvement of Liver Transplantation by a Sphingosine Kinase Inhibitor

$258,766
Zhi Zhong · Apogee Biotechnology Corporation · R41 · FY2009 · DK

Preclinical Therapeutics

$258,763
Frank Patrick McCormick · University Of California, San Francisco · P30 · FY2013 · CA

The Endocannabinoid System in hepatic Injury and Fibrosis

$258,759
Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2009 · DK

The Endocannabinoid System in hepatic Injury and Fibrosis

$258,759
Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2008 · DK

Control of drug and ethanol metabolism

$258,674
Gavin E Arteel · University Of Louisville · R01 · FY2008 · AA

Control of drug and ethanol metabolism

$258,674
Gavin E Arteel · University Of Louisville · R01 · FY2009 · AA

Control of drug and ethanol metabolism

$258,674
Gavin E Arteel · University Of Louisville · R01 · FY2007 · AA

BIOENERGETICS AND ALCOHOLIC LIVER DISEASE PATHOGENESIS

$258,629
Johns Hopkins University · R01 · FY2001 · AA

Potential Mechanisms of Glucagon-like peptide-1 in Fatty Liver Disease

$258,570
Frank A. Anania · Emory University · R01 · FY2007 · DK